RA) is set to release its Q4 and full-year 2024 financial results, with analysts predicting an EPS of $0.17 and revenues of approximately $274.6 million.ProAssurance Corporation (NYSERA) is a prominent specialty insurer, primarily focusing on medical professional liability. As a key player in the insurance industry, ProAssurance competes with other major insurers, offering tailored solutions to meet the unique needs of healthcare professionals. The company is set to release its fourth-quarter and full-year 2024 financial results on February 24, 2025, after the market closes.
Wall Street analysts estimate ProAssurance's earnings per share (EPS) to be $0.17 for the upcoming quarterly report, with projected revenues of approximately $274.6 million. However, analysts from Zacks Investment Research have a slightly different outlook, anticipating an EPS of $0.15 and revenues of $272 million. This discrepancy highlights the varying expectations among analysts, which can influence investor sentiment.
Despite the anticipated revenue decline of 4.6% compared to the previous year, ProAssurance's projected EPS of $0.15 represents a remarkable 400% year-over-year improvement. This significant growth in earnings is attributed to increased investment income and reduced costs, which have bolstered the company's financial performance in the fourth quarter.
For the entire year of 2024, ProAssurance's revenues are estimated to be around $1.11 billion, reflecting a slight decrease of 0.5% from the previous year. However, the projected EPS of $0.80 for 2024 marks a substantial recovery from the previous year's loss of $0.14. This recovery underscores the company's ability to navigate challenges and improve its profitability.
ProAssurance's financial metrics, such as a price-to-earnings (P/E) ratio of 17.24 and a price-to-sales ratio of 0.64, provide insight into the market's valuation of the company. The debt-to-equity ratio of 0.36 indicates a balanced approach to financing, with a moderate level of debt relative to shareholders' equity. These metrics, along with the company's earnings yield of 5.80%, offer a comprehensive view of ProAssurance's financial health and market position.
